1 |
Leon |
Aarons |
University of
Manchester |
UK |
2 |
Ann |
Allen |
SmithKline Beecham |
England |
3 |
MAGALI |
ANDANSON |
SERVICE DE
PHARMACOLOGIE CLINIQUE - Pr BOISSEL |
FRANCE |
4 |
Bill |
Bachman |
GloboMax LLC |
USA |
5 |
Misba |
Beerahee |
GlaxoWellcome |
UK |
6 |
Pascale |
Bernillon |
INSERM |
France |
7 |
Elisa |
Berno |
University of Torino |
Italy |
8 |
Graham |
Blakey |
Astra Charnwood |
UK |
9 |
Frederic Yves |
BOIS |
INSERM |
France |
10 |
François |
BOUZOM |
Technologie Servier |
France |
11 |
Rene |
Bruno |
Rhone-Poulenc Rorer |
France |
12 |
Samantha |
Carmichael |
Imperial Cancer
Research Fund |
UK |
13 |
BRUNO |
CHARPIAT |
CROIX-ROUSSE Hospital |
FRANCE |
14 |
Paul |
Chevalier |
Rhône-Poulenc Rorer |
France |
15 |
Chantal |
Csajka |
Division of Clinical
Pharmacology |
Swizerland |
16 |
Marie |
Cullberg |
Astra Hassle |
Sweden |
17 |
Anthony |
Davison |
EPFL |
Switzerland |
18 |
Oscar |
Della Pasqua |
GlaxoWellcome
Research & Development |
UK |
19 |
Carlo |
Della Pepa |
University of Torino |
Italy |
20 |
Alfonso |
Domínguez-Gil Hurlé |
Universidad de
Salamanca |
España |
21 |
Stephen |
Duffull |
University of
Manchester |
UK |
22 |
Mario |
Eandi |
University of Torino |
Italy |
23 |
Karin |
Fattinger |
Div. of Clinical
Pharmacology, University Hospital |
Switzerland |
24 |
Agneta |
Freijs |
Division of
Biopharmaceutics and Pharmacokinetics |
Sweden |
25 |
Nicolas |
FREY |
IRIS |
France |
26 |
GILLES |
FREYER |
Centre Hospitalier
Lyon-Sud |
FRANCE |
27 |
Tomoo |
Funaki |
Nippon Roche K.K. |
Japan |
28 |
Eliane |
FUSEAU |
GlaxoWellcome |
UK |
29 |
Mª José |
García Sánchez |
Universidad de
Salamanca |
España |
30 |
Ronald |
Gieschke |
F.Hoffmann-La Roche |
Switzerland |
31 |
Pascal |
Girard |
Service Pharmacologie
Clinique, EA643 |
France |
32 |
Carla |
Gomeni |
Biotrial |
France |
33 |
Roberto |
Gomeni |
Zeneca Pharma |
France |
34 |
Gordon |
Graham |
University of
Manchester |
UK |
35 |
Lutz |
Harnisch |
HMR |
Germany |
36 |
Tracy |
Higgins |
Covance CRU |
England |
37 |
Nils Ove |
Hoem |
University of Oslo |
Norway |
38 |
Philip |
Jarvis |
Zeneca |
UK |
39 |
Roger |
Jelliffe |
USC School of
Medicine |
USA |
40 |
Byron |
Jones |
De Montfort
University |
UK |
41 |
Niclas |
Jonsson |
Uppsala University |
Sweden |
42 |
Siv |
Jonsson |
Uppsala University,
Dep of Pharmacy/Div of Biopharmaceutics and Pharmacokinetics |
Sweden |
43 |
Fredrik |
Jonsson |
National Institute
for Working Life |
Sweden |
44 |
Martin |
Karlberg |
Astra Arcus AB |
Sweden |
45 |
Mats |
Karlsson |
Uppsala University |
Sweden |
46 |
William |
knebel |
GloboMax LLC |
USA |
47 |
Ritu |
Lal |
Abbott Laboratories |
USA |
48 |
Jose M. |
Lanao |
University of
Salamanca |
Spain |
49 |
CHRISTIAN |
LAVEILLE |
IRIS |
FRANCE |
50 |
patricia |
Lefebvre |
Rhône-Poulenc Rorer |
France |
51 |
Chantal |
LE GUELLEC |
Pharmacology |
FRANCE |
52 |
Michael |
Looby |
Pfizer Limited |
England |
53 |
Thomas |
Ludden |
GloboMax |
USA |
54 |
Harry |
Mager |
Bayer AG |
Germany |
55 |
Alain |
Mallet |
University of paris
6, INSERM |
france |
56 |
Pierre |
Maitre |
Clinique de Genolier |
Switzerland |
57 |
Scott |
Marshall |
Pfizer Limited |
England |
58 |
jean xavier |
Mazoit |
Université Paris-sud |
France |
59 |
Peter |
Mccormack |
ASTRA |
UK |
60 |
France |
Mentre |
INSERM U436 |
France |
61 |
Yann |
MERLÉ |
INSERM U436 |
FRANCE |
62 |
Peter |
Milligan |
Pfizer Limited |
England |
63 |
Ruth |
Oliver |
GloboMax |
USA |
64 |
Per |
Olsson |
GlaxoWellcome R&D |
UK |
65 |
Gilles |
PAINTAUD |
Laboratory of
Pharmacology and Toxicology |
France |
66 |
BELA |
PATEL |
SMITHKLINE BEECHAM |
USA |
67 |
Poul Chr. |
Pedersen |
Novo Nordisk A/S |
Denmark |
68 |
Helen |
Pentikis |
GloboMax |
USA |
69 |
Olivier |
PETRICOUL |
GlaxoWellcome R&D |
ENGLAND |
70 |
Vladimir |
Piotrovsky |
Janssen Research
Foundation |
Belgium |
71 |
Maria |
Pitsiu |
Medeval Ltd |
UK |
72 |
christian |
Pobel |
C.H. Saintes |
France |
73 |
Ruedi |
Port |
German Cancer
Research Center |
Germany |
74 |
Sylvie |
Retout |
Rhone-Poulenc Rorer |
France |
75 |
Ferdinand |
Rombout |
Bayer AG, Business
Group Pharma, Institute of Clinical Pharmacology |
Germany |
76 |
Marie |
Sandström |
Dep of Pharmacy, Div.
of Biopharmaceutics and Pharmacokinetics |
Sweden |
77 |
Mª Dolores |
Santos Buelga |
Universidad de
Salamanca |
España |
78 |
Hans |
Schaefer |
ELI LILLY AND COMPANY |
UK |
79 |
Norbert |
Schmidt |
Bayer AG |
Germany |
80 |
Rik |
Schoemaker |
CHDR |
Netherlands |
81 |
Jagdev |
Sidhu |
SmithKline Beecham |
U.K. |
82 |
Nicolas |
Simon |
Parke-Davis |
France |
83 |
Lena |
Simonsen |
Uppsala University |
Sweden |
84 |
Guilherme |
Suarez-Kurtz |
Instituto Nacional de
Cancer, Brazil |
Brazil |
85 |
Tanigawa |
Takahiko |
Bayer Yakuhin,Ltd. |
Japan |
86 |
Paul |
Tanswell |
Boehringer Ingelheim
Pharma KG |
Germany |
87 |
Alison |
Thomson |
University of Glasgow |
Scotland |
88 |
Christiane |
Tillmann |
Eli Lilly |
United Kingdom |
89 |
MICHEL |
TOD |
CHU AVICENNE |
FRANCE |
90 |
Brigitte |
Tranchand |
Centre Léon-Bérard |
France |
91 |
David |
Tudor |
Novartis Pharma, AG |
Switzerland |
92 |
LUC |
VAN OBBERGH |
ANESTHESIOLOGY |
BELGIUM |
93 |
Christine |
Veyrat-Follet |
Rhone-Poulenc Rorer |
France |
94 |
Nicole |
Vivier |
Rhone-Poulenc Rorer |
France |
95 |
Janet |
Wade |
MPA |
Sweden |
96 |
Ulrika |
Wählby |
Uppsala University |
Sweden |
97 |
Jeff |
Wald |
Pharsight |
USA |
98 |
Estelle |
Watson |
University of
Manchester |
UK |
99 |
Willi |
Weber |
Aventis Hoechst |
Germany |
100 |
Paul |
Williams |
University of the
Pacific |
USA |